Cell-Easy
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- $5.8M
Investors
- 3
About Cell-Easy
Founded in 2018 and based in Toulouse, France, Cell-Easy SAS operates as a developer and manufacturer of stem cell contracts that are made for preclinical and clinical drug development.
Who invested in Cell-Easy
3 investors across 2 rounds
See all investors in Cell-Easy
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cell-Easy
Who invested in Cell-Easy?
Cell-Easy has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cell-Easy raised?
Cell-Easy has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cell-Easy last raise money?
Cell-Easy's most recent round on record is a Series A, in Apr 2022.
What does Cell-Easy do?
Founded in 2018 and based in Toulouse, France, Cell-Easy SAS operates as a developer and manufacturer of stem cell contracts that are made for preclinical and clinical drug development.
Where is Cell-Easy headquartered?
Cell-Easy is headquartered in Toulouse, France.
Which VCs invest in companies like Cell-Easy?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Cell-Easy's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Cell-Easy? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.